Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 3 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Digital photographing apparatus and control method for evaluating validity of an auto-focus operation
Cell proliferation inhibitor
Reflective mask blank and method of manufacturing a reflective mask
Modular storage system
Method and apparatus for analysis of histopathology images and its application to cancer diagnosis and grading
Variety corn line NPAA2720
Wireless refrigerant scale platform
  Randomly Featured Patents
Photographic products and processes
Arrangement for determining the mass of a stream of tobacco, or other constituent material of smokers' products
Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
Game device, game processing method, information recording medium, and program
Donor material for carbonless copying and coating composition for the same
Methods and compositions for treatment of asthma
Combined device and service discovery technique in stations supporting tunneled direct link setup (TDLS)
Shadow mask assembly used in color cathode ray tube
Charge pump circuits and methods
Method of performing cell search in wireless communication system